Oral Abstract Session
AKI Trials, Therapeutics, and Risk Stratification
October 24, 2026 | 04:30 PM - 06:00 PM
Location: Room 603, Convention Center
Session Description
Oral Abstract Session
Learning Pathway(s)
- AKI and Critical Care
Moderators
Presentations
One-Year Outcomes of an Accelerated vs. Standard Kidney Replacement Therapy Initiation Strategy for AKI: Results from the STARRT-AKI Trial
Hierarchical Composite End Points in the LIBERATE-D Trial: A Post Hoc Analysis
Evaluating Fluid-Management Parameters During CRRT: Results from the CRRTnet Registry
SERENIA: A Phase 2a Study to Assess the Safety, Efficacy, and Tolerability of AZD4144 in Sepsis-Associated AKI
Terlipressin and Kidney Replacement Therapy in Patients with Hepatorenal Syndrome-AKI Ineligible for Liver Transplantation: An Exploratory Subgroup Analysis of the CONFIRM Trial
Feasibility and Acceptability of a Randomized Clinical Trial of SGLT2 Inhibitors in Heart Failure-Associated AKI
Rates of In-Hospital SGLT2 Inhibitor Discontinuation After AKI
A Multicenter Artificial Intelligence Prediction Model Identifies Distinct Preoperative Risk Profiles for Postoperative Acute Kidney Disease
Nutritional Status as Predictor of Mortality in Older Adults with AKI